Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > PR
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(16)
•••
Comment by jopatcloon Nov 27, 2024 10:50am
21 Views
Post# 36333508

RE:RE:RE:RE:RE:RE:RE:RE:PR

RE:RE:RE:RE:RE:RE:RE:RE:PREnough the sheep see now 0.135$  GranhamB. He is a manipulative vulture with several fake accounts here and on ceo with several sheep following him to denigrate Ventripoint for many years.
V:VPT - VentriPoint Diagnostics Ltd. - https://www.ventripoint.com
Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr Open-Hi-Lo Year Hi-Lo Last Tr News Delay
VPT - V   10.5 0.13 · 0.135 45.5 0.135 +0.005 3.8 26.6 3 9 0.13  0.135  0.13 0.36  0.115 09:55:03 Nov 22 15 min RT 2¢
TSX-V - V 10.5 0.13 · 0.135 45.5 0.135 +0.005 3.8 26.0 3 7 0.13  0.135  0.13 0.36  0.115 09:55:03   15 min
Omega - O   0.135 +0.005 3.8 0.5   1 0.135  0.135  0.135   09:50:51   15 min
CXD - D   0.13     0.07   1        Nov 22   15 min

 

 

Recent Trades - All 9 today
Time ET Ex Price Change Volume Buyer Seller Markers
09:55:03 V 0.135 0.005 500 7 TD Sec 7 TD Sec K
09:50:51 O 0.135 0.005 500 19 Desjardins 2 RBC K
09:48:29 V 0.13   12,500 7 TD Sec 7 TD Sec K
09:39:16 V 0.13   1,000 19 Desjardins 7 TD Sec K
09:31:14 V 0.13   1,000 19 Desjardins 7 TD Sec K
09:30:02 V 0.13   5,000 1 Anonymous 7 TD Sec K
09:30:00 D 0.13   71 7 TD Sec 7 TD Sec E
09:30:00 V 0.13   5,000 85 Scotia 7 TD Sec KL
09:30:00 V 0.13   1,000 80 National Bank 7 TD Sec KL
               

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities